Negative Pressure Wound Therapy Market Size was valued at USD 3.88 Billion in 2023. The Global Negative Pressure Wound Therapy industry is projected to grow from USD 4.06 Billion in 2024 to USD 5.90 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 4.77% during the forecast period (2024 - 2032). The demand for certified Negative Pressure Wound Therapy NPWT products is rising, and chronic diseases such as obesity and diabetes mellitus majorly drive the NPWT devices market growth. These are just a few of the market drivers that are driving the market.
Smith+Nephew, a medical technology company, has introduced its RENASYS EDGE Negative Pressure Wound Therapy (NPWT) System in the United States in April 2024. The RENASYS NPWT system is intended to enhance the quality of home-based care for patients with chronic wounds. The NPWT System is intended to enhance the quality of home-based care for patients with chronic wounds, including ulcers. The system is engineered to be discreet, compact, and lightweight, and it can be effortlessly worn or carried. Additionally, it operates silently. It is equipped with a canister. The RENASYS EDGE system's user-friendly interface provides step-by-step guidance on therapy applications, and technical support is easily accessible through a near-field communication feature.. Additionally, Smith+Nephew provides the product with a dedicated clinical hotline and round-the-clock customer service. The company has also disclosed partnerships with First Nation Group and SunMED Medical Solutions to distribute the RENASYS EDGE System nationwide. Laura Ackerman, vice-president and general manager of Smith+Nephew NPWT, stated, "We prioritized patients and their requirements during the development of the RENASYS EDGE System." It is the very essence of our mission - Life Unlimited - to enable patients to continue with their daily routines while receiving negative pressure wound therapy as prescribed.
ExtriCARE USA, a pioneer in advanced wound care solutions, is pleased to announce the release of the ExtriCARE 1000 Negative Pressure Wound Therapy (NPWT) System in March 2024. By integrating potent functionality with a lightweight design, this innovative device introduces a new era for NPWT, catering to the diverse requirements of healthcare providers and patients. The tailored approach of the ExtriCARE 1000 establishes a new standard in wound care therapy. This system enables the development of personalized treatment plans for patients with a variety of wound types, with a primary emphasis on closed incisional wounds, and offers three pressure settings and two operational modes (continuous or intermittent). The device's 50cc canister effectively regulates exudate to prevent complications such as skin maceration or pooling. The ExtriCARE 1000 is compact and lightweight, weighing only 0.5 lbs., making it easy to use in a variety of care settings. It is specifically designed to ensure patient comfort and mobility. Mobility is its primary characteristic, and ExtriCARE's dedication to providing enduring value in wound care management is evidenced by its continuous support that is not time-limited.
Source: Secondary Research, MRFR Database, Primary Research, and Analyst Review
An increasing prevalence of chronic diseases, such as diabetes, is presenting a large patient pool suffering from its comorbidity, i.e., diabetic foot ulcers. For instance, according to a report published by the NHS in 2017, an approx. Of 4.5 million people who had diabetes in the United Kingdom and around 10.0% of the diabetic population were recorded with foot ulcers. On top of that, the rising geriatric population affected by various diseases and conditions is resulting in decreasing mobility among senior patients. It is one of the major negative pressure wound therapy device market trends. Such trends are projected to fuel the demand for treatment and boost the adoption of vacuum-assisted closure devices during the study period.
Additionally, the Rising number of surgical plans of action ly is caused by a large patient pool affected by surgical wounds, and it is estimated to propel the market growth of the negative pressure wound therapy during the projected period. Negative pressure wound therapy has developed over the past few years to provide wound healing rapidly. An advanced NPWT device gives a treatment that can also be used in the outpatient setting for lots of wounds, varying from postoperative slits to wounds that are completely necrotic. Such launch of advanced & cost-efficient NPWT is anticipated to fuel the demand resulting in being the major driver for the market CAGR during the forecast period.
Figure 1: Negative Pressure Wound Therapy chart
Source: Secondary Research, MRFR Database, Primary Research, and Analyst Review
Moreover, the handiness of novel and advanced NPWT devices, which are sufferer-friendly and uncomplicated to use, propel the negative pressure wound therapy devices market growth. Nevertheless, the lack of skilled professionals and difficulties caused by the use of negative pressure wound therapy devices obstruct the growth of the NPWT market. Conversely, rising focus on advanced treatment protocols, significant unmet requirements in the wound care field, and high market potential in emerging economies are expected to serve as profitable opportunities for market enlargement. Reportedly, growing awareness about the effective nature of advanced wound care treatments, like NPWT technology, across underdeveloped economies will enlarge the negative pressure wound therapy market size during the prospective years. Thus, this aspect is projected to quicken the negative pressure on wound therapy market revenue worldwide.
The NPWT Market segmentation, based on wound type, this category is segmented into traumatic wounds, surgical wounds, ulcers, and burns. The ulcer wounds segment dominated the market and accounted for the largest revenue share, according to the negative pressure wound therapy market data, due to greater treatment duration. Patients with pressure ulcers stay for a long duration when in hospitals, thereby surging hospital costs. One more factor to such growth is the emerging application in treating pressure wounds such as bedsores. However, the surgical wounds segment is estimated to register the highest growth rate, attributed to an increase in the prevalence of surgical wounds.
The NPWT Market segmentation, based on end-users, this category has two segments; hospitals and others. The hospital segment is anticipated to have the dominant market during the study period in negative pressure wound therapy market data due to the huge patient pool with acute or chronic diseases in hospitals. For instance, according to a report by the Nursing Times, every year, the number of hospitalized patients in the U.K. is estimated to be approx. 20,000 who endure pressure ulcers.
However, the home care segment is expected to record a large share of the NPWT devices in the market. This can be owing to the rising prevalence of age-related ailments, increasing the sale of disposables and single-use consumables, and rising healthcare costs will contribute to negative pressure on wound therapy market revenue.
Figure 2: Chart Negative Pressure Wound Therapy Market, by end-users, 2024 & 2032 (USD Billion)
Source: Secondary Research, MRFR Database, Primary Research, and Analyst Review
By region, the study states the market insights into North America, Asia-Pacific, Europe, and the Rest of the World. North America's NPWT market accounted for USD 2.5 billion in 2022, with a share of around 6.10%, and is expected to show a significant CAGR growth during the forecast period. The market is estimated to be fueled by the rising geriatric population, low-cost NPWT devices, and increasing incidence of chronic wounds and diabetes are the main factors fueling the extension of the NPWT devices market in North America.
Further, the major countries studied in the market report are The U.S., Canada, Germany, France, the U.K., Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 3: CHART FOR NEGATIVE PRESSURE WOUND THERAPY MARKET SHARE BY REGION 2022 (%)
Source: Secondary Research, MRFR Database, Primary Research, and Analyst Review
Europe’s NPWT market accounts for the third-largest market share. However, Europe is expected to grow at a comparatively lower pace during the forecast period. Inadequate compensation policies for negative pressure wound therapy, mainly in the major European countries, including France, Spain, and Italy, are limiting the adoption of negative pressure wound therapy devices in this region. Market. Moreover, the UK Negative Pressure Wound Therapy Device market held the largest market share, and the Germany Negative Pressure Wound Therapy market was the fastest-growing market in the region.
Asia Pacific's negative pressure wound therapy device market is expected to grow at a quick CAGR from 2022 to 2030 and hold the second-largest share. The rapid increase in chronic wounds due to chronic diseases in this region and technological advances in negative pressure wound therapy devices are the prime reason that is significantly promoting the market growth. According to the IDF, approx. of 1.07 billion people aged 20 to 79 years suffer from diabetes in China. Further, the China negative pressure wound therapy market held the largest market share, and the Indian negative pressure wound therapy device market was the fastest-growing market in the region.
Negative Pressure Wound Therapy Key Market Players & Competitor Insights
Main market players are spending a lot of money on Research and Development to grow their product lines, which will assist the market of negative pressure wound therapy to grow even more. Competitors are also making strategies to grow their footprints with key market developments, such as mergers and acquisitions, new product launching, partnerships, increased investments, and collaboration with other organizations. Participants in the negative pressure wound therapy industry must give cost-effective items to enlarge and rise in a highly competitive and rising market environment.
One of the primary business strategies adopted by manufacturers in the negative pressure wound therapy industry for advantages to clients and to expand the market sector is to produce locally to reduce operating costs. In recent years, the Negative Pressure Wound Therapy industry has provided medicine with some of the most significant benefits. The NPWT Market major player such as ACELITY L. P. Inc., Cardinal Health, ConvaTec Group Plc., and Smith & Nephew.
In 1856, Thomas James Smith opened a chemist shop in Hull, UK, and developed a new method for refining cod liver oil; later, Horatio Smith entered a partnership with his uncle from TJ Smith & Nephew. This medical technology company is occupied with developing and marketing medical devices for use in trauma, and orthopedic reconstruction, sports medicines, ENT, and advanced wound management. The company offers knee and hip implants to substitute diseased, damaged, or worn joints; robotics-assisted enabling technologies. For example, in March 2020, Smith+Nephew, the medical technology business, made an announcement to the U.S. about the set up of the PICO 14 single-use NPWT system for use on high-risk surgical patients.
Cardinal Health, Inc. (NYSE: CAH), headquartered in Dublin, Ohio, is a distributor of pharmaceuticals, a producer and distributor of medical and laboratory products, and a giver of performance and data solutions for healthcare facilities. For instance, in March 2022, Cardinal Health introduced the first surgical incise drape launch using chlorhexidine gluconate (CHG). Cardinal Health presumed this new drape could help improve patient care by lowering the risk of microbial contamination.
Key Companies in the Negative Pressure Wound Therapy market include
January 2022:ConvaTec Group PLC made an announcement about the acquisition of Triad Life Sciences, Inc. ConvaTec believes that it would allow them to subsume the wound biologics segment.
November 2021:Medela LLC made an announcement regarding the release of new data that suggests that the Medela Invia Liberty Negative Pressure Wound Therapy System outperforms other multi-lumen NPWT systems available in the market. The data demonstrated how Medela’s Invia Liberty NPWT system could clear 89% of the fluid bolus challenge and re-establish prescribed pressure within 20 minutes.
| Report Attribute/Metric | Details |
| Market Size 2022 | USD 3.88 billion |
| Market Size 2024 | USD 4.6 billion |
| Market Size 2032 | USD 5.90 billion |
| Compound Annual Growth Rate (CAGR) | Â 4.77% (2024-2032) |
| Base Year | 2023 |
| Market Forecast Period | 2024-2032 |
| Historical Data | 2018 - 2021 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Growth Factors, Market Competitive Landscape, and Trends |
| Segments Covered | Wound Type, And End-Users |
| Geographies Covered | North America, Asia Pacific, Europe, and the Rest of the World |
| Countries Covered | The U.S, Canada, Germany, France, the U.K., Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled | ACELITY L. P. Inc., Cardinal Health, ConvaTec Group Plc., Smith & Nephew, Talley Group, Medela, Genadyne |
| Key Market Opportunities | Growing spending on chronic and surgical wounds |
| Key Market Dynamics | increasing frequency of chronic diseases such as diabetes and obesity, increasing causalities |
Negative Pressure Wound Therapy Market Highlights:
Frequently Asked Questions (FAQ) :
The negative pressure wound therapy market size was recorded at USD 3.88 Billion in 2023.
The market is projected to grow at a CAGR of 4.77% during the study period, 2024-2032.
North America has held the largest share of the market
The key players in the market are ACELITY L. P. Inc., Cardinal Health, ConvaTec Group Plc., Smith & Nephew, Talley Group, Medela, Genadyne, and others.
The ulcers category dominated the market for negative pressure wound therapy in 2022.
The hospital had the largest share of the market for negative pressure wound therapy.
Research Analyst Level I He is an extremely curious individual currently working in healthcare and medical devices domain. kinjoll is comfortably versed in data centric research backed by healthcare educational background. he leverages extensive data mining and analytics tools such as primary and secondary research, statistical analysis, machine learning, data modelling. his key role also involves technical sales support, client interaction and project management within the healthcare team. lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
